MedEx answers any queries you might have regarding Revlimid-5 purchase, shipping and payment terms.
Feel free to contact support through inquiry form, MedeEx is fully dedicated towards your needs 24/7.
The new medication Revlimid, that proved to be particularly effective in most cases of use, can be found on the modern market.
Revlimid has been approved by European Commission and US Food and Drug Administration for the treatment of severe diseases. Nowadays, it can be used by the patients with myelodysplastic syndrome and lymphoma.
This drug is used in combination with Dexamethasone for the treatment of patients with myeloma. The drug can be used one after the patient had received chemotherapy. This drug is an immunomodulator – the substance that affects immune system and has anti-angiogenic properties.
The main component of Revlimid is Lenalidomide.
This drug can be used only under the supervision of chemotherapist or hematologist. Standard treatment course lasts 28 days, whereas the doctor can regulate and duration of therapy and define the drug dose. Common single dose is 25 mg once a day (which was enough in most cases). However, the health professional can regulate your dose. This drug is contraindicated for pregnant and breastfeeding women, children and patients with intolerance to lactose and other components of this drug. Despite the positive characteristics of Revlimid, its contraindications cover almost all organs and systems of the body, which means that this drug can be used only under the medical supervision. This drug can be dangerous for the patients with certain levels of platelets or neutrophils.
Revlimid, is an immunomodulator, which affects the existing tumor. This drug is a representative of the new drug class, which directly affects the human immune system and has anti-angiogenic properties.
Older people and patients suffering from severe kidney pathology and multiple myeloma, who take Dexamethasone (as this drug has erythropoetic activity), should use Revlimid with extreme caution. You should be careful while mixing hormones with Revlimid, as such combination can increase the risk of thrombosis.
Capsules of Revlimid should be taken orally, without breaking or chewing. The drug must be used at the same time each day before/after the meal with a glass of water.
The recommended initial dose of Revlimid is 25 mg once a day (1-21 days of cycle). The entire treatment cycle includes 28 days.
The use of Revlimid can cause side effects, such as: muscle weakness, reduced level of neuthrophils and platelets in blood, general weakness, constipation, muscle cramps, anemic syndrome, stomach upset and rash.
In most cases, the patients who used Revlimid left positive feedbacks about the drug. It helped to prolong the life of many patients.